Aging hearts, fibrotic fears: The sirtuin connection

Area of Science:

• Biochemistry
• Cardiology
• Molecular Biology

Background:

• Sirtuins (NAD+-dependent enzymes) are crucial for metabolic regulation, aging, oxidative stress, and inflammation, processes linked to myocardial fibrosis.
• Cardiac fibrosis, characterized by excessive extracellular matrix, is a major pathological feature of heart failure.
• Specific sirtuins (SIRT1, SIRT3, SIRT6) show protective effects against fibrosis, while others like SIRT4 may promote it.

Purpose of the Study:

• To explore the multifaceted roles of sirtuins (SIRT1-SIRT7) in the development of cardiac fibrosis.
• To elucidate the regulatory mechanisms influencing sirtuin expression and function in the context of cardiac fibrosis.
• To highlight sirtuins as potential biomarkers and therapeutic targets for cardiac fibrosis.

Main Methods:

• Review of existing literature on sirtuins and cardiac fibrosis.
• Analysis of the interplay between sirtuins, non-coding RNAs, and histone modifications.
• Examination of feedback loops involving sirtuins, mitochondrial homeostasis, AMPK, and endothelial-to-mesenchymal transition (EndoMT).

Main Results:

• Sirtuins play a complex, context-dependent role in cardiac fibrosis.
• SIRT1, SIRT3, and SIRT6 demonstrate antifibrotic properties by inhibiting fibroblast activation and reducing damage.
• SIRT4's role in fibrosis is context-dependent, potentially promoting it.
• Non-coding RNAs and histone modifications significantly regulate sirtuin expression.

Conclusions:

• Sirtuins are key regulators of cardiac fibrosis, acting as both potential markers and therapeutic targets.
• Understanding the intricate regulatory networks of sirtuins is essential for developing effective anti-fibrotic strategies.
• Targeting sirtuin pathways offers promising avenues for treating heart failure associated with cardiac fibrosis.